Gene · 23308
Papers2,855
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,855
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug Discovery in the Age of Artificial Intelligence: Transformative Target-Based Approaches. | Int J Mol Sci | 2024 | 39596300 | PubTator, text mining | PubMed |
| TDO2 inhibition counters Benzo[a]pyrene-induced immune evasion and suppresses tumorigenesis in lung adenocarcinoma. | Cancer Metab | 2024 | 39593177 | PubTator, text mining | PubMed |
| The protozoan commensal Tritrichomonas musculis is a natural adjuvant for mucosal IgA. | J Exp Med | 2024 | 39535524 | PubTator, text mining | PubMed |
| ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis. | J Immunother Cancer | 2024 | 39532433 | PubTator, text mining | PubMed |
| Predictive biomarkers for immune checkpoint efficacy: is multi-omics breaking the deadlock? | Transl Lung Cancer Res | 2024 | 39507024 | PubTator, text mining | PubMed |
| Peripheral immune profiling of soft tissue sarcoma: perspectives for disease monitoring. | Front Immunol | 2024 | 39502689 | PubTator, text mining | PubMed |
| Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model. | J Control Release | 2024 | 39481685 | PubTator, text mining | PubMed |
| Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention. | Front Immunol | 2024 | 39450169 | PubTator, text mining | PubMed |
| Immune marker expression and prognosis of early breast cancer expressing HER3. | Eur J Cancer | 2024 | 39447449 | PubTator, text mining | PubMed |
| Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC. | Front Oncol | 2024 | 39411143 | PubTator, text mining | PubMed |
| Assessment of pDCs functional capacity upon exposure to tumor-derived soluble factors. | Methods Cell Biol | 2024 | 39393888 | PubTator, text mining | PubMed |
| Development of T follicular helper cell-independent nanoparticle vaccines for SARS-CoV-2 or HIV-1 by targeting ICOSL. | NPJ Vaccines | 2024 | 39341822 | PubTator, text mining | PubMed |
| Alterations in circulating immunoregulatory proteins discriminate poor CD4 T lymphocyte trajectories in people with HIV on suppressive antiretroviral therapy. | mBio | 2024 | 39287441 | PubTator, text mining | PubMed |
| Identifying genetically-supported drug repurposing targets for non-small cell lung cancer through mendelian randomization of the druggable genome. | Transl Lung Cancer Res | 2024 | 39263038 | PubTator, text mining | PubMed |
| Correction to Supporting Information for Tili et al., MiR-155-targeted IcosL controls tumor rejection. | Proc Natl Acad Sci U S A | 2024 | 39250674 | PubTator, text mining | PubMed |
| ICOS-ICOSL pathway enhances NKT-like cell antiviral function in pregnant women with COVID-19. | Int J Med Sci | 2024 | 39113896 | PubTator, text mining | PubMed |
| Differential response of IgM and IgG memory B cell populations to CD40L: insights of T cell - memory B cell interactions. | Front Immunol | 2024 | 39050849 | PubTator, text mining | PubMed |
| Chemotherapy resistance in acute myeloid leukemia is associated with decreased anti-tumor immune response through MHC molecule and B7 family members. | Discov Oncol | 2024 | 38861194 | PubTator, text mining | PubMed |
| An integrated analysis of the structural changes and gene expression of spleen in human visceral leishmaniasis with and without HIV coinfection. | PLoS Negl Trop Dis | 2024 | 38843306 | PubTator, text mining | PubMed |
| Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus. | Cancer Gene Ther | 2024 | 38839891 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23308/papers?page=6